中国防痨杂志 ›› 2021, Vol. 43 ›› Issue (12): 1332-1335.doi: 10.3969/j.issn.1000-6621.2021.12.018
收稿日期:
2021-06-24
出版日期:
2021-12-10
发布日期:
2021-12-01
通信作者:
李传友
E-mail:lichuanyou6688@hotmail.com
基金资助:
YANG Rui-fang*, LI Chuan-you()
Received:
2021-06-24
Online:
2021-12-10
Published:
2021-12-01
Contact:
LI Chuan-you
E-mail:lichuanyou6688@hotmail.com
摘要:
成簇的规律间隔短回文重复序列(clustered regularly interspaced short palindromic repeats,CRISPR)和他们相关的蛋白(Cas)组成了一个新的分布于结核分枝杆菌(MTB)的获得性免疫防御系统。此外,CRISPR-Cas系统与MTB的毒力、耐药以及定向基因编辑方面可能存在重要的关系。笔者主要通过对CRISPR-Cas系统在MTB的免疫作用及其相关研究进展进行综述,以期为进一步研究MTB致病性和抗结核治疗提供一种新思路。
杨瑞芳, 李传友. CRISPR-Cas系统在结核分枝杆菌研究中的应用进展[J]. 中国防痨杂志, 2021, 43(12): 1332-1335. doi: 10.3969/j.issn.1000-6621.2021.12.018
YANG Rui-fang, LI Chuan-you. Research progress of relationship between CRISPR-Cas system and Mycobacterium tuberculosis[J]. Chinese Journal of Antituberculosis, 2021, 43(12): 1332-1335. doi: 10.3969/j.issn.1000-6621.2021.12.018
[1] |
Khawbung JL, Nath D, Chakraborty S. Drug resistant Tuberculosis: A review. Comp Immunol Microbiol Infect Dis, 2021, 74:101574. doi: 10.1016/j.cimid.2020.101574.
doi: 10.1016/j.cimid.2020.101574 URL |
[2] |
Hryhorowicz M, Lipinski D, Zeyland J, et al. CRISPR/Cas9 Immune System as a Tool for Genome Engineering. Arch Immunol Ther Exp (Warsz), 2017, 65(3):233-240. doi: 10.1007/s00005-016-0427-5.
doi: 10.1007/s00005-016-0427-5 URL |
[3] |
Liu L, Fan XD. CRISPR-Cas system: a powerful tool for genome engineering. Plant Mol Biol, 2014, 85(3):209-218. doi: 10.1007/s11103-014-0188-7.
doi: 10.1007/s11103-014-0188-7 URL |
[4] |
Koonin EV, Makarova KS. Origins and evolution of CRISPR-Cas systems. Philos Trans R Soc Lond B Biol Sci, 2019, 374(1772):20180087. doi: 10.1098/rstb.2018.0087.
doi: 10.1098/rstb.2018.0087 URL |
[5] |
Koonin EV, Makarova KS. Mobile Genetic Elements and Evolution of CRISPR-Cas Systems:All the Way There and Back. Genome Biol Evol, 2017, 9(10):2812-2825. doi: 10.1093/gbe/evx192.
doi: 10.1093/gbe/evx192 URL |
[6] |
翟小倩, 鲍朗. CRISPR-Cas系统及其在结核分枝杆菌中的研究进展. 生物学杂志, 2018, 35(1):89-92. doi: 10.3969/j.issn.2095-1736.2018.01.089.
doi: 10.3969/j.issn.2095-1736.2018.01.089 |
[7] |
Wei J, Lu N, Li Z, et al. The Mycobacterium tuberculosis CRISPR-Associated Cas1 Involves Persistence and Tolerance to Anti-Tubercular Drugs. Biomed Res Int, 2019, 2019:7861695. doi: 10.1155/2019/7861695.
doi: 10.1155/2019/7861695 |
[8] |
冯欢欢, 单彩龙, 李金月, 等. CRISPR系统中Cas蛋白的分类及作用机制. 中国病原生物学杂志, 2018, 13(6):652-654, 663. doi: 10.13350/j.cjpb.180624.
doi: 10.13350/j.cjpb.180624 |
[9] |
Chen H, Zhang SD, Chen L, et al. Efficient Genome Editing of Magnetospirillum magneticum AMB-1 by CRISPR-Cas9 System for Analyzing Magnetotactic Behavior. Front Microbiol, 2018, 9:1569. doi: 10.3389/fmicb.2018.01569.
doi: 10.3389/fmicb.2018.01569 URL |
[10] | 黄琴琴. 结核分枝杆菌Cas2(Rv2816c)在胁迫应答及胞内存活中的作用与分子机理. 重庆:西南大学, 2015. |
[11] |
Killelea T, Bolt EL. CRISPR-Cas adaptive immunity and the three Rs. Biosci Rep, 2017, 37(4):BSR20160297. doi: 10.1042/BSR20160297.
doi: 10.1042/BSR20160297 |
[12] |
Plagens A, Richter H, Charpentier E, et al. DNA and RNA interference mechanisms by CRISPR-Cas surveillance complexes. FEMS Microbiol Rev, 2015, 39(3):442-463. doi: 10.1093/femsre/fuv019.
doi: 10.1093/femsre/fuv019 pmid: 25934119 |
[13] |
Wei W, Zhang S, Fleming J, et al. Mycobacterium tuberculosis type Ⅲ-A CRISPR/Cas system crRNA and its maturation have atypical features. FASEB J, 2019, 33(1):1496-1509. doi: 10.1096/fj.201800557RR.
doi: 10.1096/fj.201800557RR URL |
[14] |
Larson MH, Gilbert LA, Wang X, et al. CRISPR interference (CRISPRi) for sequence-specific control of gene expression. Nat Protoc, 2013, 8(11):2180-2196. doi: 10.1038/nprot.2013.132.
doi: 10.1038/nprot.2013.132 URL |
[15] |
Gilbert LA, Larson MH, Morsut L, et al. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell, 2013, 154(2):442-451. doi: 10.1016/j.cell.2013.06.044.
doi: 10.1016/j.cell.2013.06.044 pmid: 23849981 |
[16] |
Qi LS, Larson MH, Gilbert LA, et al. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell, 2013, 152(5):1173-1183. doi: 10.1016/j.cell.2013.02.022.
doi: 10.1016/j.cell.2013.02.022 URL |
[17] | 刘雅婷. 结核分枝杆菌Cas蛋白表达纯化与功能研究. 郑州:郑州大学, 2012. |
[18] |
Zhang Y, Yang J, Bai G. Regulation of the CRISPR-Associated Genes by Rv2837c (CnpB) via an Orn-Like Activity in Tuberculosis Complex Mycobacteria. J Bacteriol, 2018, 200(8):e00743-17. doi: 10.1128/JB.00743-17.
doi: 10.1128/JB.00743-17 |
[19] |
Liu Z, Dong H, Cui Y, et al. Application of different types of CRISPR/Cas-based systems in bacteria. Microb Cell Fact, 2020, 19(1):172. doi: 10.1186/s12934-020-01431-z.
doi: 10.1186/s12934-020-01431-z URL |
[20] |
Sander JD, Joung JK. CRISPR-Cas systems for editing, regulating and targeting genomes. Nat Biotechnol, 2014, 32(4):347-355. doi: 10.1038/nbt.2842.
doi: 10.1038/nbt.2842 URL |
[21] |
Cong L, Ran FA, Cox D, et al. Multiplex genome engineering using CRISPR/Cas systems. Science, 2013, 339(6121):819-823. doi: 10.1126/science.1231143.
doi: 10.1126/science.1231143 pmid: 23287718 |
[22] |
Li Y, Peng N. Endogenous CRISPR-Cas System-Based Genome Editing and Antimicrobials:Review and Prospects. Front Microbiol, 2019, 10:2471. doi: 10.3389/fmicb.2019.02471.
doi: 10.3389/fmicb.2019.02471 URL |
[23] |
Yan MY, Li SS, Ding XY, et al. A CRISPR-Assisted Nonhomologous End-Joining Strategy for Efficient Genome Editing in Mycobacterium tuberculosis. mBio, 2020, 11(1):e02364-19. doi 10.1128/mBio.02364-19.
doi: 10.1128/mBio.02364-19 |
[24] |
Rock J. Tuberculosis drug discovery in the CRISPR era. PLoS Pathog, 2019, 15(9):e1007975. doi: 10.1371/journal.ppat.1007975.
doi: 10.1371/journal.ppat.1007975 URL |
[25] |
Rock JM, Hopkins FF, Chavez A, et al. Programmable transcriptional repression in mycobacteria using an orthogonal CRISPR interference platform. Nat Microbiol, 2017, 2:16274. doi: 10.1038/nmicrobiol.2016.274.
doi: 10.1038/nmicrobiol.2016.274 URL |
[26] |
郭越, 赵增祥, 张文姝, 等. 基因编辑调控技术在结核分枝杆菌基因功能研究中的应用进展. 中国病原生物学杂志, 2020, 15(4):483-486. doi: 10.13350/j.cjpb.200425.
doi: 10.13350/j.cjpb.200425 |
[27] |
Singh A, Gaur M, Sharma V, et al. Comparative Genomic Analysis of Mycobacteriaceae Reveals Horizontal Gene Transfer-Mediated Evolution of the CRISPR-Cas System in the Mycobacterium tuberculosis Complex. mSystems, 2021, 6(1):e00934-20. doi: 10.1128/mSystems.00934-20.
doi: 10.1128/mSystems.00934-20 |
[28] |
Zhang S, Li T, Huo Y, et al. Mycobacterium tuberculosis CRISPR/Cas system Csm1 holds clues to the evolutionary relationship between DNA polymerase and cyclase activity. Int J Biol Macromol, 2021, 170:140-149. doi: 10.1016/j.ijbiomac.2020.12.014.
doi: 10.1016/j.ijbiomac.2020.12.014 URL |
[29] |
Gunderson FF, Cianciotto NP. The CRISPR-associated gene cas2 of Legionella pneumophila is required for intracellular infection of amoebae. mBio, 2013, 4(2):e00074-13. doi: 10.1128/mBio.00074-13.
doi: 10.1128/mBio.00074-13 |
[30] |
Lam JT, Yuen KY, Ho PL, et al. Truncated Rv2820c enhances mycobacterial virulence ex vivo and in vivo. Microb Pathog, 2011, 50(6):331-335. doi: 10.1016/j.micpath.2011.02.008.
doi: 10.1016/j.micpath.2011.02.008 URL |
[31] |
Rindi L, Lari N, Garzelli C. Genes of Mycobacterium tuberculosis H37Rv down regulated in the attenuated strain H37Ra are restricted to M.tuberculosis complex species. New Microbiol, 2001, 24(3):289-294.
pmid: 11497087 |
[32] | 吴晓丽. 结核分枝杆菌Csm3蛋白功能的初步研究. 福州:福建农林大学, 2016. |
[33] |
Makarova KS, Wolf YI, Alkhnbashi OS, et al. An updated evolutionary classification of CRISPR-Cas systems. Nat Rev Microbiol, 2015, 13(11):722-736. doi: 10.1038/nrmicro3569.
doi: 10.1038/nrmicro3569 pmid: 26411297 |
[34] |
Hatfull GF. Molecular Genetics of Mycobacteriophages. Microbiol Spectr, 2014, 2(2):1-36. doi: 10.1128/microbiolspec.MGM2-0032-2013.
doi: 10.1128/microbiolspec.MGM2-0032-2013 pmid: 25328854 |
[35] |
Ren L, Deng LH, Zhang RP, et al. Relationship between drug resistance and the clustered, regularly interspaced, short, palindromic repeat-associated protein genes cas1 and cas2 in Shigella from giant panda dung. Medicine (Baltimore), 2017, 96(7):e5922. doi: 10.1097/MD.0000000000005922.
doi: 10.1097/MD.0000000000005922 URL |
[36] |
Brudey K, Driscoll JR, Rigouts L, et al. Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol, 2006, 6:23. doi: 10.1186/1471-2180-6-23.
doi: 10.1186/1471-2180-6-23 URL |
[1] | 首都医科大学附属北京胸科医院/北京市结核病胸部肿瘤研究所, 中国防痨协会《中国防痨杂志》编辑委员会. 耐药肺结核全口服化学治疗方案中国专家共识(2021年版)[J]. 中国防痨杂志, 2021, 43(9): 859-866. |
[2] | 周文强, 张爽, 初乃惠. 耐药肺结核全口服治疗方案研究的现状和展望[J]. 中国防痨杂志, 2021, 43(9): 879-882. |
[3] | 石文卉, 初乃惠. 耐药肺结核患者氟喹诺酮类药物耐药情况及影响因素[J]. 中国防痨杂志, 2021, 43(9): 905-909. |
[4] | 林建, 林淑芳, 戴志松, 赵永, 周银发, 张添林, 魏淑贞. 2016—2019年福建省结核病耐药监测结果分析[J]. 中国防痨杂志, 2021, 43(9): 924-928. |
[5] | 于霞, 任汝颜, 文舒安, 梁倩, 董玲玲, 黄海荣. 13种抗生素对快生长分枝杆菌的体外抑菌效果评价[J]. 中国防痨杂志, 2021, 43(9): 947-951. |
[6] | 马婷婷, 任斐, 马进宝, 杨翰. 异烟肼耐药肺结核患者对丙硫异烟胺和对氨基水杨酸的耐药情况分析[J]. 中国防痨杂志, 2021, 43(9): 961-964. |
[7] | 夏辉, 赵雁林. 世界卫生组织《关于更新使用结核分枝杆菌及其耐药性核酸扩增检测技术的建议》的启示[J]. 中国防痨杂志, 2021, 43(8): 761-765. |
[8] | 胡严杰, 龚世伟, 任易. 核酸内切酶Surveyor酶切法快速检测MTB对吡嗪酰胺耐药性方法的建立及评估[J]. 中国防痨杂志, 2021, 43(8): 813-816. |
[9] | 杨婷婷, 高谦. 构建基于全基因组数据的结核病耐药及传播监测网络[J]. 中国防痨杂志, 2021, 43(7): 645-648. |
[10] | 易俊莉, 杨新宇, 陈昊, 赵琰枫, 陈双双, 张洁, 丁北川, 代小伟, 孙闪华, 武文清, 李传友. 1156株结核分枝杆菌临床分离株耐药情况分析[J]. 中国防痨杂志, 2021, 43(7): 677-681. |
[11] | 曹盼, 梁矿立, 袁吉欣, 李永波, 陈瑞, 张志飞, 仵倩红. 初治与复治空洞性利福平耐药肺结核患者的CT表现分析[J]. 中国防痨杂志, 2021, 43(7): 694-701. |
[12] | 常俊丽, 张建宏, 章瑛, 张海芳, 凡鹏飞, 李秋华, 丁雪玲. 一起学校利福平耐药肺结核聚集性疫情的调查分析[J]. 中国防痨杂志, 2021, 43(7): 751-754. |
[13] | 罗丹, 覃慧芳, 叶婧, 赵锦明, 秦翊翔, 蓝如束. 广西壮族自治区结核分枝杆菌耐药基因突变特征及其与基因型的相关性分析[J]. 中国防痨杂志, 2021, 43(6): 596-601. |
[14] | 王璐, 薛仲探, 王玉峰, 尚媛媛, 任卫聪, 姚丛, 高飞, 逄宇. 结核分枝杆菌对贝达喹啉药物敏感性动态监测及耐药制研究[J]. 中国防痨杂志, 2021, 43(5): 482-486. |
[15] | 刘敏, 李明俊, 余庆, 何坤, 吴玉珊, 杨红红, 李同心. 重庆市HIV与NTM双重感染患者的菌种分布及耐药情况[J]. 中国防痨杂志, 2021, 43(5): 501-505. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||